Literature DB >> 2797644

Binding of epidermal growth factor and insulin-like growth factor I in human myometrium and leiomyomata.

P Tommola1, F Pekonen, E M Rutanen.   

Abstract

Samples of uterine myometrium and leiomyoma from 11 women were analyzed for the presence of epidermal growth factor receptors and insulin-like growth factor I receptors. In addition, the content of soluble insulin-like growth factor binding protein (IGF-BP/PP12) was measured in the tissue cytosols. Cell membrane preparations of myoma tissue bound significantly more insulin-like growth factor I than did those of adjacent normal myometrium, whereas myoma tissue bound less epidermal growth factor than did the normal myometrium. The differences in both insulin-like growth factor I and epidermal growth factor binding were due to changes in receptor concentration rather than to alterations in receptor affinity. Neither myoma nor myometrial tissue contained detectable levels of insulin-like growth factor binding protein. The changes in epidermal growth factor and insulin-like growth factor I binding to the myometrium may play a role in the pathogenesis of uterine leiomyomata.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2797644

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  History of uterine leiomyoma and risk of endometrial cancer in black women.

Authors:  Lauren A Wise; Todd R Sponholtz; Lynn Rosenberg; Lucile L Adams-Campbell; Wendy Kuohung; Michael P LaValley; Julie R Palmer
Journal:  Cancer Causes Control       Date:  2016-02-29       Impact factor: 2.506

2.  Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation.

Authors:  Erica N Nierth-Simpson; Melvenia M Martin; Tung-Chin Chiang; Lilia I Melnik; Lyndsay V Rhodes; Shannon E Muir; Matthew E Burow; John A McLachlan
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

3.  Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.

Authors:  Linda Yu; Katrin Saile; Carol D Swartz; Hong He; Xiaolin Zheng; Grace E Kissling; Xudong Di; Shantelle Lucas; Stanley J Robboy; Darlene Dixon
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

4.  Purification and partial sequencing of the major mitogen for human uterine smooth muscle-like cells in leiomyoma extracts.

Authors:  A Sourla; M Koutsilieris
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

5.  Expression of insulin-like growth factors (IGFs), their receptors and IGF binding protein-3 in normal, benign and malignant smooth muscle tissues.

Authors:  L T Van der Ven; P J Roholl; T Gloudemans; S C Van Buul-Offers; M J Welters; B A Bladergroen; J A Faber; J S Sussenbach; W Den Otter
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 6.  Human Chorionic Gonadotrophin as a Possible Mediator of Leiomyoma Growth during Pregnancy: Molecular Mechanisms.

Authors:  Veronica Sarais; Greta Chiara Cermisoni; Matteo Schimberni; Alessandra Alteri; Enrico Papaleo; Edgardo Somigliana; Paola Vigano'
Journal:  Int J Mol Sci       Date:  2017-09-20       Impact factor: 5.923

Review 7.  Etiology and pathogenesis of uterine leiomyomas: a review.

Authors:  Gordon P Flake; Janet Andersen; Darlene Dixon
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

8.  Submucous fibroids and infertility: Effect of hysteroscopic myomectomy and factors influencing outcome.

Authors:  K Jayakrishnan; Vandana Menon; Divya Nambiar
Journal:  J Hum Reprod Sci       Date:  2013-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.